Download Pneumocystis carinii Infection Presenting as Necrotizing Thyroiditis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Syndemic wikipedia , lookup

Infection wikipedia , lookup

Focal infection theory wikipedia , lookup

Infection control wikipedia , lookup

Index of HIV/AIDS-related articles wikipedia , lookup

Transcript
MARTIN-REAY, SHATTUCK, AND GUTHRIE
489
Psammomatous Melanotic Schwannoma
19. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VLW. The
complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270-283.
20. Carney JA, Headington JT, Su WPD. Cutaneous myxomas. A major
component of the complex of myxomas, spotty pigmentation
and endocrine overactivity. Arch Dermatol 1986;122:790-798.
21. Cook CA, Lund BA, Carney JA. Mucocutaneous pigmented spots
and oral myxomas: the oral manifestations of the complex of
myxomas, spotty pigmentation and endocrine overactivity. Oral
Surg Oral Med Oral Pathol 1987;63:175-183.
22. Schweizer-Cagianut M, Salomon F, Hedinger CE. Primary adre-
nocortical nodular dysplasia with Cushing's syndrome and cardiac
myxomas. A peculiar familial disease. Virchows Arch [A]
1982;397:183-192.
23. Shennoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented
nodular adrenocortical disease. Rare cause of the Cushing's syndrome. Am J Surg Pathol 1984;8:335-344.
24. Vatterott PJ, Seward JB, Vidaillet JH, Su WPD, Oftedahl GL. Syndrome cardiac myxoma: more than just a sporadic event. Am
Heart J 1987;114:886-889.
25. Proppe KH, Scully RE. Large-cell calcifying Sertoli cell tumor of
the testis. Am J Clin Pathol 1980;74:607-619.
Pneumocystis carinii Infection Presenting as
Necrotizing Thyroiditis and
Hypothyroidism
MARGARET V. RAGNI, M.D., ANDREW DEKKER, M.D.,
FREDERICK R. D E R U B E R T I S , M.D., CHARLES G. WATSON, M.D.,
M. LEON SKOLNICK, M.D., SUSAN D. GOOLD, M.D., MICHAEL W. FINIKIOTIS, M.D.,
SALIL DOSHI, M.D., AND DELYNNE J. MYERS, M.D.
Extrapulmonary Pneumocystis infection has been increasingly
reported in patients with acquired immune deficiency syndrome
(AIDS), in particular, recently in association with the increasing
use of aerosolized pentamidine. This report describes the unusual
presentation of extrapulmonary Pneumocystis infection as a
thyroid neck mass and clinical hypothyroidism in a 37-year-old
man with hemophilia and AIDS. This case differs from the previously reported single case of isolated thyroid pneumocystosis
in the presence of a rapidly enlarging neck mass, lack of previous
Pneumocystis, and prior prophylaxis with aerosolized pentamidine. The pathologic and electron microscopic description of the
peculiar flocculent necrotic thyroid material is contrasted with
typical pulmonary alveolar findings in Pneumocystis pneumonia
(PCP), the differential diagnoses of a rapidly expanding neck
mass, and diagnostic difficulties of hypothyroidism in patients
with AIDS are discussed. Finally, it is emphasized that use of
aerosolized pentamidine, although successful for prevention of
pulmonary PCP, may be insufficient to prevent extrapulmonary
infection. (Key words: Pneumocystis carinii pneumonia |PCPJ;
Acquired immune deficiency syndrome (AIDS); Extrapulmonary
pneumocystosis; Thyroid mass) Am J Clin Pathol 199I;95:
489-493
Despite advances in treatment and prophylaxis, Pneumocystis carinii pneumonia (PCP) continues to be the
most c o m m o n opportunistic infection reported in patients
with acquired immune deficiency syndrome (AIDS), with
more than 60% of patients with AIDS presenting with
PCP and another 20% having PCP as a later diagnosis.1,2
Although PCP is regarded as a primary pulmonary pathogen, there have been increasing reports of extrapulmonary
Pneumocystis infection.3"5 These may relate, in part, to
the recent introduction of aerosolized pentamidine, 6
which, with only minimal systemic absorption,7 promotes
eradication of pulmonary Pneumocystis while allowing
unchecked development of nonpulmonary Pneumocystis.
Recently we cared for a patient with hemophilia and AIDS
who presented with an acute diffuse goiter, hypothyroidism, and P. carinii of the thyroid.
REPORT OF A CASE
From the Departments ofMedicine. Radiology, Surgery, and Pathology,
University of Pittsburgh School ofMedicine, and the Hemophilia Center A 37-year-old man with severe hemophilia A (< 0.01 U/mL Factor
of Western Pennsylvania, Pittsburgh, Pennsylvania.
VIII:C) and AIDS presented in July 1989 with a painful right neck mass
and transient dysarthria. There had been no trauma. Ultrasound revealed
Received March 8, 1990; received revised manuscript and accepted
the mass to be an enlarged right lobe of the thyroid, with echogenic areas
for publication April 5, 1990.
consistent with calcification and suggestive of hematoma. The left lobe
Address reprint requests to Dr. Ragni: Hemophilia Center of Western
appeared normal. Treatment with Factor VIII concentrate therapy rePennsylvania, 812 Fifth Avenue, Pittsburgh, Pennsylvania 15219.
Vol. 95 • No. 4
490
ANATOMIC PATHOLOGY
Single Case Reports
FIG. 1 (upper). Transverse ultrasound scan through right lobe of thyroid, 10/89. Hyperechoic regions (H) and regions of acoustic (S) suggest presence
of calcifications. A, carotid artery; V, jugular vein; L, laryngeal cartilage.
FIG. 2 (lower). Transverse postcontrast computerized tomographic scan of entire thyroid confirms presence of calcification (C) in both lobes, more
so in the left lobe. A, carotid artery; V, jugular vein; L, laryngeal cartilage.
A.J.C.P. • April 1991
RAGNI ET AL.
Pneumocystis Infection of the Thyroid
suited in cessation of pain and minimal decrease in size of the neck mass.
Neurologic examination, lumbar puncture, and computerized tomographic (CT) scan of the head were unremarkable. Thyroid function tests
revealed T4 of 131 nmol/L (normal 63-130), T3 uptake of 0.88 (normal,
0.8-1.2), free thyroxine index of 9.0 (normal, 5.0-12.0), and thyroidstimulating hormone (TSH) levels of 2.8 mU/L (normal 0.5-10.0). In
October 1989, at a routine semiyearly examination, diffuse massive
painless enlargement of the thyroid gland was observed, unrecognized
by the patient or his wife, which was accompanied by a 12-pound weight
loss in four weeks, anorexia, irritability, and fatigue. There were no sweats,
fevers, odynophagia, hoarseness, or precedent trauma. A 90-pound weight
loss had occurred over the preceding year, associated with intermittent
nonwatery, culture-negative diarrhea. A diagnosis of AIDS was made in
May 1989, when the patient presented with Candida esophagitis. Medications included zidovudine (AZT) I g daily for the previous 15 months,
ketoconazole 100 mg daily for the previous 5 months, and aerosolized
pentamidine 300 mg monthly (via Respirgard II®, Marquest Medical
Products, Inc., Englewood, CO) for the previous 7 months. Physical
examination revealed a temperature of 36.9 °C, blood pressure 104/60
mmHg, pulse 80 per minute. The skin was dry and doughy, with significant wasting. Speech and mentation were slowed, and deep tendon
reflexes could not be elicited. The thyroid gland was firm, nontender,
and diffusely enlarged, with the right lobe measuring 9 X 4 cm and the
left lobe measuring 8 X 3 cm. Lymph nodes in the posterior cervical
and anterior cervical chain were enlarged (0.5 — 1.5 cm) bilaterally.
Hepatosplenomegaly was present. Ultrasonography revealed a diffusely
491
enlarged gland, right greater than left, with echogenic regions and shadowing suggestive of calcifications bilaterally (Fig. 1). Computed tomography scan confirmed thesefindings:the right lobe measured 9 X 4 X 3
cm and the left lobe 8 X 3 X 3 cm with bilateral calcification (Fig. 2).
Thyroid function tests revealed T4 of 49 nmol/L, T3 uptake of 0.64 (0.81.2) and a TSH level of 33 mU/L. Antithyroglobulin and antimicrosomal
antibodies were negative at less than 100. The thyroid-binding globulin
level was 60 nmol/L (15-31). Afine-needlebiopsy and tru-cut biopsy
of the right lobe of the thyroid gland, performed under coverage of Factor
VIII concentrate, revealed significantly abnormal thyroid tissue of a pale
pink color. Cytologic results revealed macrophages but no malignant
cells. Hematoxylin and eosin staining revealed extensive necrosis with a
peculiar flocculent appearance (Fig. 3); in addition, there was granulomatous inflammation with extensive destruction and gross distortion of
the thyroid architecture. Only occasional thyroid follicles were present,
confirmed by immunoperoxidase keratin (Fig. 3, inset) and thyroglobulin
staining. Extensive calcification was present throughout the tissue sections
(not shown). P. carinii organisms were detected on Grocott staining of
both the tissue section (Fig. 4) and the decolorized glass slides originally
prepared for cytologic examination and were confirmed by electron microscopic examination of the deparaffinized tru-cut tissue block (Fig. 5).
Thefindingsof pulmonary examination, chest roentgenogram, gallium
scan, and pulmonary function tests were normal and pulse oximetry
was 96%. Abdominal CT scan revealed hepatosplenomegaly with no
focal defects and multiple, bilateral, small renal cortical calcifications.
The adrenals appeared normal, with no calcifications. Skin testing re-
^ . w
•
#
*
*
FIG. 3 (left). Granulomatous inflammation andflocculentmaterial seen in a low-power photomicrograph. Thyroid follicle at arrow. Inset. Thyroid
follicle as shown by immunoperoxidase keratin stain. Hematoxylin and eosin (XI25). Inset (X312).
FIG. 4 (right). Typical Pneumocystis carinii organisms demonstrated. Grocott (X 1,250).
Vol. 95 • No. 4
492
ANATOMIC PATHOLOGY
Single Case Reports
FIG. 5. Electron micrograph of Pneumocystis
carinii. Lead citrate and uranyl acetate
(X22.700).
vealed reactivity to mumps and Trichophyton antigens but no reactivity
with purified protein derivative (PPD).
The patient was treated with a three-week course of intravenous pentamidine at 4 mg/kg, with gradual shrinkage of the gland and cessation
of weight loss. Thyroid replacement was begun with synthetic T4 (Synthroid®; sodium levothyroxine. Flint Laboratories, Deerfield, IL), 75 fig
daily. The patient is currently receiving prophylaxis with aerosolized
pentamidine and oral Bactrim® (trimethoprim-sulfamethoxazole; Roche
Laboratories, Nutley, NJ) and continues on maintenance thyroid replacement.
DISCUSSION
With the high frequency of P. carinii pneumonia in
patients with AIDS and the increasing use of recently approved aerosolized pentamidine prophylaxis, it is not surprising that extrapulmonary Pneumocystis infection has
been recognized in patients with AIDS more frequently
in the past several years.3"5 Although the thyroid gland
has been an involved site in a number of disseminated
cases, there has been only one previous case of isolated
Pneumocystis infection of the thyroid.8 In contrast to that
patient, the hemophiliac reported here had no previous
pulmonary symptoms, had been receiving chronic
monthly aerosolized pentamidine prophylaxis, and presented with diffuse goiter and hypothyroidism. Given the
nonspecific symptoms typical of patients with AIDS, such
as weight loss, intermittent diarrhea, mental slowing, fatigue, and depression, a clinical diagnosis of hypothyroidism in a patient with AIDS may be difficult to make.
Further, hypothyroidism is uncommon in patients with
AIDS because most such patients have normal thyroid
function,9 or occasionally a low T 3 level, which may ac-
company a severe infection, the so-called "euthyroid sick
syndrome." Moreover, in the setting of the severe immunosuppression associated with AIDS and a rapidly
growing neck mass, thyroid lymphoma is a more likely
diagnosis,10 especially because lymphomas in human immunodeficiency virus- (HIV) positive hemophiliacs have
previously presented as "hematomas" in unusual sites."
However, the absence of malignant cells on biopsy specimens and the clinical response to pentamidine and thyroid hormone (T4) exclude the possibility of thyroid lymphoma or other malignancy in this patient.
Two clues to the pathologist for the proper recognition
of the disease processes are12 the peculiar flocculent nature
of the necrotic material, not dissimilar to that seen in the
alveoli of lungs of patients infected with Pneumocystis,
and 5 the granulomatous inflammatory infiltrate observed
in the tissue section, and recently emphasized in PCP. 13
Further, although electron microscopic examination is not
required for the diagnosis of P. carinii infection, when it
is performed, as in this case, it confirms the typical morphologic characteristics of the organism,12 specifically
demonstrating the presence of intact cysts and intracystic
bodies. Because the latter are eradicated with systemic
pentamidine therapy,12 their presence confirms the clinical
absence of any systemic effect of aerosolized pentamidine
in this patient.
The importance of this case, aside from the recognition
that extrapulmonary Pneumocystis infection can present
as thyroiditis with hypothyroidism, is the growing recognition of the increasing frequency of extrapulmonary
AJ.C.P. • April 1991
RAGNI ET AL.
493
Pneumocystis Infection of the Thyroid
Pneumocystis in patients with AIDS. This observation
suggests that aerosolized pentamidine should be recommended as only part of an effective prophylaxis regimen
to prevent Pneumocystis infection in such patients. The
combination of intermittent oral trimethoprim-sulfamethoxazole (Bactrim) or intermittent intravenous pentamidine or Bactrim, for example, with aerosolized pentamidine might be considered; unfortunately, the minimal
effective dose of such drugs, when used in combination,
is not known. In summary, this case illustrates three major
points12: extrapulmonary Pneumocystis infection may
present as thyroiditis with hypothyroidism5; "hematomas"
in unusual sites in HIV-infected hemophiliacs may represent opportunistic infection; and1 aerosolized pentamidine prophylaxis alone may be insufficient to prevent
extrapulmonary Pneumocystis infection.
Acknowledgments. The authors acknowledge Dr. Julio A. Martinez
for performing electron microscopic studies, Dr. Janet Amico for helpful
advice, and Michele Macom for preparation of the manuscript.
REFERENCES
1. Centers for Disease Control. HIV/AIDS surveillance report- -United
States. October 1989:1-16.
2. Hopewell PC. Pneumocystis carinii pneumonia: diagnosis. J Infect
Dis 1988;157:1115-1119.
3. Raviglione MC, Mariuz P, Sugar J, Mullen MP. Extrapulmonary
Pneumocystis infection. Ann Intern Med 1989; 111:339.
4. Richie TL, Yamaguchi E, Virani NA, Quinn BD, Chaisson RE.
Extrapulmonary Pneumocystis infection. Ann Intern Med
1989;111:339-340.
5. Case records of the Massachusetts General Hospital (case 9—1989).
N Engl J Med 1989;320:582-587.
6. Girard PM, Landman R, Gaudebout C, et al. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in
zidovudine-treated AIDS patients. Lancet 1989;1:1348-1353.
7. Conte JE, Hollander H, Golden JA. Inhaled or reduced dose of
intravenous pentamidine for Pneumocystis carinii pneumonia: a
pilot study. Ann Intern Med 1987;107:495-498.
8. Gallant JE, Enriquez RE, Cohen K.L, Hammers LW. Pneumocystis
carinii thyroiditis. Am J Med 1988;84:303-306.
9. Lopresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alternations
of thyroid hormone indices in the acquired immunodeficiency
syndrome (AIDS). Ann Intern Med 1989; 110:970-975.
10. Kapadia SB, Dekker A, Cheng VS, Desai UMA, Watson CG. Malignant lymphoma of the thyroid gland: a clinicopathologic study.
Head Neck Surg 1982;4:270-280.
11. Ragni MV, Lewis JH, Bontempo FA, Spero JA. Lymphoma presenting as a traumatic hematoma in an HTLV-II1 antibody positive hemophiliac. N Engl J Med 1985;313:640.
12. Campbell WG. Ultrastructure of Pneumocystis in human beings.
Arch Pathol 1972;93:312-324.
13. Cupples JB, Blackie SP, Road JD. Granulomatous Pneumocystis
carinii pneumonia mimicking tuberculosis. Arch Pathol Lab Med
1989:113:1281.
Malignant Peritoneal Mesothelioma in
Childhood with Long-term Survival
WILLIAM A. GEARY, M.D., P H . D . , STACEY E. MILLS, M.D.,
HENRY F. FRIERSON, J R . , M.D., AND THOMAS L. POPE, M.D.
A diffuse, well-differentiated, malignant peritoneal mesothelioma
(MPM) developed in a nine-year-old girl. She received limited
chemotherapy and radiation therapy and is alive and well without
clinical evidence of disease 109 months after diagnosis. The neoplastic cells stained immunohistochemically for cytokeratin and
epithelial membrane antigen but were unreactive with B72.3,
anti-carcinoembryonic antigen, and anti-Leu-Ml. Ultrastructurally, the tumor cells had abundant desmosomes, numerous
tonofilament bundles, and variable-length microvilli. These findings confirm the mesothelial nature of the cells. Features con-
sistent with malignancy included DNA aneuploidy by flow cytometric analysis and diffuse peritoneal involvement. The three
previously described survivors with MPM were also premenarchal girls. Some MPMs in premenarchal girls have an indolent
biologic behavior similar to that of low-grade peritoneal serous
neoplasia or well-differentiated papillary mesothelioma in adult
women. (Key words: Mesothelioma; Childhood; Immunohistochemistry; Flow cytometry; DNA analysis; Peritoneum; B72.3;
Leu-Ml; Carcinoembryonic antigen; Cytokeratin; Epithelial
membrane antigen) Am J Clin Pathol 1991;95:493-498
Most malignant peritoneal mesotheliomas (MPMs) occur
men, many of whom have a history of asbestos exposure.12 Long-term survival in adults with MPMs is distinctly uncommon. The rare MPMs occurring in childhood have several important clinical differences from their
adult counterparts.3"7 In children, MPMs have no clearcut association with asbestos exposure and no male predilection. Furthermore, isolated examples of survival in
From the Departments of Pathology and Radiology. University of Virin
ginia Health Sciences Center, Charlottesville, Virginia.
Received April 19, 1990; received revised manuscript and accepted
for publication July 12, 1990.
Dr. Pope is currently a member of the Department of Radiology,
Bowrri£.:i Gray Medical Center, Winston-Salem, North Carolina.
Address reprint requests to Dr. Mills: Department of Pathology, Box
214, University ofVirginia Health Sciences Center, Charlottesville, Virginia 22908.
Vol. 95 • No. 4